BRAUNWALD
ET AL., MANAGEMENT OF PATIENTS WITH UNSTABLE ANGINA AND NON-ST-SEGMENT
ELEVATION MYOCARDIAL INFARCTION UPDATE
http://www.acc.org/clinical/guidelines/unstable/incorporated/index.htm
ACC/AHA
2002 Guideline Update for the Management of Patients With Unstable
Angina and Non-ST-Segment Elevation Myocardial Infarction
A
Report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee on the Management of
Patients With Unstable Angina)
Figure
9. The use of LMWH in UA showing effects
on the triple end points of death, MI, and recurrent ischemia with
or without revascularization. Early (6-day) and intermediate outcomes
of the 4 trials that compared LMWH and UFH: ESSENCE (169),
TIMI 11B (170), FRIC
(218), and FRAXIS (219).
Nadroparine in FRAXIS was given for 14 days.

|